274 IMPROVED SUSTAINED VIROLOGIC RESPONSE (SVR) RATES IN “DIFFICULT-TO-CURE” PATIENTS TREATED WITH TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN: AN ANALYSIS FROM THE PROVE3 STUDY

✍ Scribed by M.P. Manns; A.J. Muir; N. Adda; J.G. McHutchison; N. Terrault; L. Bengtsson; S. George; A.M. Di Bisceglie

• Book ID: 117378360
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 48 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(10)60276-0